Ragada El-Damanawi, Isabelle Kitty Stanley, Christine Staatz, Elaine M Pascoe, Jonathan C Craig, David W Johnson, Andrew J Mallett, Carmel M Hawley, Elasma Milanzi, Thomas F Hiemstra, Andrea K Viecelli
BACKGROUND: Metformin has been used in the management of diabetes for decades. It is an effective, low-cost intervention with a well-established safety profile. Emerging evidence suggests that metformin targets a number of pathways that lead to chronic kidney damage, and long-term use may, therefore, slow the rate of kidney function decline and chronic kidney disease (CKD) progression. OBJECTIVES: To evaluate the effect of metformin therapy on kidney function decline in patients with CKD with or without diabetes mellitus and assess the safety and dose tolerability in this population...
June 4, 2024: Cochrane Database of Systematic Reviews